Pharmaceuticals, Biotechnology and Life Sciences
Novartis on Wednesday announced long-term study results supporting the positive safety and efficacy of Revolade in adults with chronic immune…
Horizon Pharma has been named one of the 2017 Best Small & Medium Workplaces by FORTUNE and Great Place to Work for the second year…
Gilead Sciences has promoted Alessandro Riva, MD, to Executive Vice President, Oncology Therapeutics, with responsibility for Gilead’s hematology and oncology programs,…
The US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for AstraZeneca’s Imfinzi (durvalumab) for the treatment of…
Frank Staud assumed the role of Executive Vice President Corporate Communications, Branding and Sponsoring on October 1. The 48-year old…
Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to…
The US Food and Drug Administration (FDA) has published the briefing documents ahead of the Advisory Committee meeting to discuss…
Fennec Pharmaceuticals revealed the data from its Phase 3 SIOPEL 6 study during the late breaker session on Saturday, October…
Silence Therapeutics has made a new appointment to its board of directors, in a significant moment in the transition of…
Omega, the medical diagnostics company focused on allergy, food intolerance and infectious disease, has signed a Supply Agreement with a…